Real-time enrollment status for this waldenstrom macroglobulinemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT06561347 |
| Recruiting Status | Recruiting |
| Condition | Waldenstrom Macroglobulinemia |
| Phase | Clinical Trial |
| Target Enrollment | 55 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | November 24, 2025 (Nov 24, 2025) |
As of March 2, 2026: Clinical trial NCT06561347 is currently recruiting participants. This clinical trial study for waldenstrom macroglobulinemia is actively seeking new participants at 3 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06561347 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06561347 was last updated Nov 24, 2025 (November 24, 2025). HelloStudys verifies this status automatically.